| 1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide |
EPZ005687 |
1396772-26-1 |
| (R)-2-aMino-2-(pyridin-3-yl)ethanol hydrochloride |
(R)-2-AMINO-2-(PYRIDIN-3-YL)ETHANOL HYDROCHLORIDE |
1391588-79-6 |
| ML417 |
ML417 |
1386162-69-1 |
| SR9009 |
SR9009 |
1379686-30-2 |
| GNE 617 |
N-[[4-[(3,5-二氟苯基)磺酰基]苯基]甲基]咪唑并[1,2-A]吡啶-6-甲酰胺 |
1362154-70-8 |
| ALK/IGF1R inhibitor |
AZD3463 |
1356962-20-3 |
| XL765 |
XL765 |
1349796-36-6 |
| N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-3-methyl-6-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide |
化合物GSK503 |
1346572-63-1 |
| S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide |
GSK126 |
1346574-57-9 |
| TP0903 |
TP-0903 |
1341200-45-0 |
| 3-(6,7-dimethoxyquinazolin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide |
3-(6,7-dimethoxyquinazolin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide |
1315330-17-6 |
| UNC 669 |
UNC669 |
1314241-44-5 |
| (R)-1-(4-fluorophenyl)butan-1-aMine hydrochloride |
(R)-1-(4-FLUOROPHENYL)BUTAN-1-AMINE HYDROCHLORIDE |
1313593-58-6 |
| LY-2940094 |
BTRX-246040 |
1307245-86-8 |
| 6-Methoxyquinoline-8-carbaldehyde |
6-Methoxyquinoline-8-carbaldehyde |
1268520-98-4 |
| SNS-062 |
SNS062 |
1270014-40-8 |
| (S)-2-aMino-2-(2-fluorophenyl)ethanol hydrochloride |
(S)-2-AMINO-2-(2-FLUOROPHENYL)ETHANOL HYDROCHLORIDE |
1269773-22-9 |
| ASP-2215 |
吉列替尼 |
1254053-43-4 |
| 1-chloro-4-iodo-2-Methoxy-5-Methylbenzene |
1-氯-4-碘-2-甲氧基-5-甲基苯 |
1246644-31-4 |
| (R)-Methyl 8-aMino-5,6,7,8-tetrahydronaphthalene-2-carboxylate hydrochloride |
(R)-METHYL 8-AMINO-5,6,7,8-TETRAHYDRONAPHTHALENE-2-CARBOXYLATE HYDROCHLORIDE |
1246509-71-6 |
QQ
